# US 2023/0348969 A1 · Methods and systems for nucleic acid sequencing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0348969 A1
- Document ID: US20230348969A1
- Status: Published application
- Kind: A1
- Application number: 18/132,703
- Filed: 2023-04-10
- Published: 2023-11-02
- Earliest claimed: 2018-07-31
- Assignees: Ultima Genomics, Inc.
- Applicants: Ultima Genomics, Inc.
- Inventors: Mark PRATT; Florian OBERSTRASS; Linda LEE; Steven MENCHEN
- Web page: https://patentgrep.com/patent/US20230348969A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6869: Methods for sequencing
- C12Q 2535/113: Cycle sequencing
- C12Q 2537/155: Cyclic reactions
- C12Q 2537/157: A reaction step characterised by the number of molecules incorporated or released
- C12Q 2549/10: the purpose being that of reducing false positive or false negative signals
- C12Y 207/07007: DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES

## Abstract

The present disclosure provides methods and systems for processing a nucleotide mixture. A nucleotide mixture can be purified. A nucleotide mixture can be processed for use in nucleic acid synthesis. A nucleotide mixture can be processed for use in nucleic acid sequencing.

## Claims

### Claim at position 1

-125. (canceled)

### Claim 126

A method for processing a mixture, comprising:
(a) selecting from a set of canonical types of nucleotides or nucleotides analogs a subset of canonical types of nucleotides or nucleotide analogs;
(b) directing a mixture comprising a plurality of nucleotides or nucleotide analogs to a reaction space comprising a support having a plurality of nucleic acid molecules immobilized thereto, wherein a percentage of nucleotides or nucleotide analogs corresponding to said subset relative to all other nucleotides or nucleotide analogs in said mixture is greater than 50%; and
(c) incorporating nucleotides or nucleotide analogs that do not correspond to said subset from said mixture into said plurality of nucleic acid molecules such that said percentage is increased following said incorporating;
wherein (a)-(c) are performed in absence of sequencing or sequence identification of said plurality of nucleic acid molecules.

### Claim 127 (depends on 126)

The method of claim 126 wherein, in (b), said percentage is greater than 80%, greater than 90%, greater than 95%, greater than 99%, greater than 99.9%, or greater than 99.99%.

### Claim 128 (depends on 126)

The method of claim 126, wherein said (c) is performed using a nucleic acid polymerizing enzyme comprising phi29 polymerase, Bst 3.0 polymerase, or a variant thereof.

### Claim 129 (depends on 126)

The method of claim 126, wherein said reaction space is further replenished with a plurality of nucleic acid polymerizing enzymes.

### Claim 130

A method for processing a mixture, comprising:
(a) selecting from a set of canonical types of nucleotides or nucleotides analogs a subset of canonical types of nucleotides or nucleotide analogs;
(b) directing a mixture comprising a plurality of nucleotides or nucleotide analogs to a reaction space comprising a support having a plurality of nucleic acid molecules immobilized thereto, wherein a percentage of nucleotides or nucleotide analogs corresponding to said subset relative to all other nucleotides or nucleotide analogs in said mixture is less than 20%; and
(c) incorporating said nucleotides or nucleotide analogs corresponding to said subset from said mixture into said plurality of nucleic acid molecules such that said percentage is reduced following incorporation,
wherein (a)-(c) are performed in absence of sequencing or sequence identification of said plurality of nucleic acid molecules.

### Claim 131 (depends on 130)

The method of claim 130, wherein, in (b), said percentage is less than 10%, less than 5%, less than 1%, less than 0.1%, or less than 0.01%.

### Claim 132 (depends on 130)

The method of claim 130, wherein said plurality of nucleotides or nucleotide analogs includes deoxynucleotides or dideoxynucleotides.

### Claim 133 (depends on 132)

The method of claim 132, wherein said plurality of nucleotides or nucleotide analogs comprises nucleotides or nucleotide analogs selected from the group consisting of deoxyadenosine triphosphate (dATP), 2′,3′-ideoxyadenosine-5′triphosphate (ddATP), deoxyguanosine triphosphate (dGTP), 2′,3′-dideoxyguanosine-5′-triphosphate (ddGTP), deoxycytidine triphosphate (dCTP), 2′,3′-dideoxycytidine-5′-triphosphate (ddCTP), deoxythymidine triphosphate (dTTP), 2′,3′-dideoxythymidine-5′-triphosphate (ddTTP), deoxyuridine triphosphate (dUTP), 2′,3′-dideoxyuridine-5′-triphosphate (ddUTP), and a variant thereof.

### Claim 134 (depends on 130)

The method of claim 130, wherein said incorporating in (c) yields double stranded nucleic acid molecules from said plurality of nucleic acid molecules comprising said nucleotides or nucleotide analogs corresponding to said subset, and wherein, subsequent to (c), said reaction space is replenished with an additional plurality of nucleic acid molecules, which additional plurality of nucleic acid molecules does not include said nucleotides or nucleotide analogs corresponding to said subset incorporated in (c).

### Claim 135 (depends on 134)

The method of claim 134, wherein said reaction space is replenished by directing an additional support immobilized with said additional plurality of nucleic acid molecules to said reaction space.

### Claim 136 (depends on 135)

The method of claim 135, wherein said support is a polymer matrix, a particle, or a fiberglass structure.

### Claim 137 (depends on 136)

The method of claim 136, wherein said particle is a bead or a gel particle.

### Claim 138 (depends on 137)

The method of claim 137, wherein said particle is said gel particle, wherein said gel particle is an aerogel particle or a hydrogel particle.

### Claim 139 (depends on 134)

The method of claim 134, wherein said reaction space is replenished by denaturation of said double stranded nucleic acid molecules and removal of resultant single stranded nucleic acid molecules that are not immobilized to said support.

### Claim 140 (depends on 139)

The method of claim 139, wherein (1) said denaturation is chemical denaturation or thermal denaturation; or (2) wherein said removal of said resultant single stranded nucleic acid molecules comprises washing, filtering, or a combination thereof.

### Claim 141

A method for synthesizing a nucleic acid molecule, comprising:
(a) directing a plurality of nucleotides or nucleotide analogs to a reaction space comprising a support having a plurality of nucleic acid molecules immobilized thereto;
(b) incorporating a subset of nucleotides or nucleotide analogs from said plurality of nucleotides or nucleotide analogs into said plurality of nucleic acid molecules, thereby providing a remainder of said plurality of nucleotides or nucleotides analogs; and
(c) using said remainder of said plurality of nucleotides or nucleotide analogs to perform nucleic acid synthesis, thereby synthesizing said nucleic acid molecule;
wherein (a)-(b) are performed in absence of sequencing or sequence identification of said plurality of nucleic acid molecules.

### Claim 142 (depends on 141)

The method of claim 141, wherein said subset consists of nucleotides or nucleotide analogs of one, two, or three canonical types.

### Claim 143 (depends on 141)

The method of claim 141, wherein said plurality of nucleic acid molecules contains nucleotides complementary to said subset of nucleotides or nucleotide analogs.

### Claim 144 (depends on 141)

The method of claim 141, wherein said plurality of nucleic acid molecules contains a greater number of nucleotides complementary to said subset of nucleotides or nucleotide analogs relative to all other nucleotides.

### Claim 145 (depends on 141)

The method of claim 141, wherein said plurality of nucleic acid molecules does not contain nucleotides that are not complementary to said subset of nucleotides or nucleotide analogs.
